William Gelson

3.4k total citations · 2 hit papers
42 papers, 1.6k citations indexed

About

William Gelson is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, William Gelson has authored 42 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hepatology, 17 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in William Gelson's work include Liver Disease and Transplantation (16 papers), Liver Disease Diagnosis and Treatment (14 papers) and Hepatitis C virus research (11 papers). William Gelson is often cited by papers focused on Liver Disease and Transplantation (16 papers), Liver Disease Diagnosis and Treatment (14 papers) and Hepatitis C virus research (11 papers). William Gelson collaborates with scholars based in United Kingdom, United States and Norway. William Gelson's co-authors include Graeme Alexander, Kosh Agarwal, William L. Irving, David Mutimer, Douglas MacDonald, Graham R. Foster, John McLauchlan, Ben Hudson, Alex J Walker and Michelle Cheung and has published in prestigious journals such as Nature Biotechnology, Hepatology and Gut.

In The Last Decade

William Gelson

37 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

2016 328 citations Graham R. Foster, William L. Irving et al. Journal of Hepatology profile →
Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation

2015 285 citations Fotios Sampaziotis, Miguel Cardoso de Brito et al. Nature Biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William Gelson United Kingdom	17	1.1k	849	304	209	198	42	1.6k
Ignacio Herrero Spain	13	496 0.4×	290 0.3×	250 0.8×	326 1.6×	196 1.0×	25	1.2k
Richard Garcia‐Kennedy United States	18	525 0.5×	552 0.7×	461 1.5×	273 1.3×	158 0.8×	35	1.4k
Joan Fabregat Spain	22	969 0.9×	614 0.7×	1.0k 3.3×	610 2.9×	186 0.9×	116	2.0k
Timothy D. Sielaff United States	20	594 0.5×	219 0.3×	733 2.4×	161 0.8×	134 0.7×	59	1.3k
Marielle Cohard France	12	943 0.8×	1.1k 1.3×	297 1.0×	185 0.9×	147 0.7×	22	1.9k
J H Hoofnagle United States	17	1.5k 1.3×	1.4k 1.7×	239 0.8×	94 0.4×	99 0.5×	23	1.9k
Stefan Lüth Germany	20	552 0.5×	599 0.7×	337 1.1×	142 0.7×	267 1.3×	75	1.4k
Hervé Zylberberg France	15	879 0.8×	820 1.0×	96 0.3×	73 0.3×	62 0.3×	21	1.2k
H.‐H. Brackmann Germany	24	501 0.4×	418 0.5×	110 0.4×	81 0.4×	336 1.7×	65	2.1k
Kai Chah Tan Singapore	13	431 0.4×	402 0.5×	227 0.7×	165 0.8×	60 0.3×	27	1.1k

Countries citing papers authored by William Gelson

Since Specialization

Citations

This map shows the geographic impact of William Gelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Gelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Gelson more than expected).

Fields of papers citing papers by William Gelson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Gelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Gelson. The network helps show where William Gelson may publish in the future.

Co-authorship network of co-authors of William Gelson

This figure shows the co-authorship network connecting the top 25 collaborators of William Gelson. A scholar is included among the top collaborators of William Gelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Gelson. William Gelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Menon, Krishna, Jamie Murphy, Pål‐Dag Line, et al.. (2023). Liver transplantation for isolated unresectable colorectal liver metastases - Protocol for a service evaluation in the United Kingdom - UKCoMET study. HPB. 25(6). 684–692.

Ercole, Ari, William Gelson, James H.F. Rudd, et al.. (2023). Moving from non-emergency bleeps and long-range pagers to a hospital-wide, EHR-integrated secure messaging system: an implementer report. BMJ Health & Care Informatics. 30(1). e100706–e100706. 2 indexed citations

Bestwick, Jonathan P., William Gelson, Kosh Agarwal, et al.. (2020). English hepatitis C registry data show high response rates to directly acting anti‐virals, even if treatment is not completed. Alimentary Pharmacology & Therapeutics. 52(1). 168–181. 8 indexed citations

Gimson, Alexander, Kosh Agarwal, Mark Aldersley, et al.. (2018). Liver transplant listing for hepatitis C‐associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct‐acting antiviral therapy. Journal of Viral Hepatitis. 26(2). 231–235. 18 indexed citations

Dolman, Grace, et al.. (2018). Ombitasvir/paritaprevir/ritonavir plus dasabuvir regimen may be used safely in combination with sirolimus for the treatment of chronic hepatitis C. BMJ Case Reports. 2018. bcr–2018. 1 indexed citations

Cheung, Michelle, Alex J Walker, Ben Hudson, et al.. (2016). Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis. Journal of Hepatology. 65(4). 741–747. 285 indexed citations

Sampaziotis, Fotios, Miguel Cardoso de Brito, Pedro Madrigal, et al.. (2015). Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation. Nature Biotechnology. 33(8). 845–852. 285 indexed citations breakdown →

Sampaziotis, Fotios, William Gelson, Alexander Gimson, et al.. (2015). A retrospective study assessing fully covered metal stents as first-line management for malignant biliary strictures. European Journal of Gastroenterology & Hepatology. 27(11). 1347–1353. 10 indexed citations

Gelson, William, et al.. (2014). Pi*Z heterozygous alpha-1 antitrypsin states accelerate parenchymal but not biliary cirrhosis. European Journal of Gastroenterology & Hepatology. 26(4). 412–417. 17 indexed citations

10.

Aravinthan, Aloysious, et al.. (2012). Hepatic sarcoidosis complicating treatment-naive viral hepatitis. World Journal of Hepatology. 4(12). 402–402. 3 indexed citations

11.

Curran, Martin D., et al.. (2010). First case of genotype 4 human hepatitis E virus infection acquired in India. Journal of Clinical Virology. 48(1). 58–61. 29 indexed citations

12.

Hoare, Matthew, William Gelson, Jean M. Fletcher, et al.. (2010). CD4+ T-lymphocyte telomere length is related to fibrosis stage, clinical outcome and treatment response in chronic hepatitis C virus infection. Journal of Hepatology. 53(2). 252–260. 47 indexed citations

13.

Gelson, William, Matthew Hoare, Sarah L. Vowler, et al.. (2010). Features of immune senescence in liver transplant recipients with established grafts. Liver Transplantation. 16(5). 577–587. 21 indexed citations

14.

Srivastava, B. I. Sahai, et al.. (2010). A confused patient with raised anti-thyroid antibodies – an unusual case. Clinical Medicine. 10(6). 605–606.

15.

Harper, Simon, William Gelson, Inês Harper, Graeme Alexander, & Paul Gibbs. (2010). Switching to Sirolimus-Based Immune Suppression After Liver Transplantation Is Safe and Effective: A Single-Center Experience. Transplantation. 91(1). 128–132. 32 indexed citations

16.

Gelson, William, Matthew Hoare, Esther Unitt, et al.. (2010). Heterogeneous Inflammatory Changes in Liver Graft Recipients With Normal Biochemistry. Transplantation. 89(6). 739–748. 12 indexed citations

17.

Unitt, Esther, William Gelson, Susan E. Davies, Nicholas Coleman, & Graeme Alexander. (2009). Minichromosome maintenance protein-2–positive portal tract lymphocytes distinguish acute cellular rejection from hepatitis C virus recurrence after liver transplantation. Liver Transplantation. 15(3). 306–312. 8 indexed citations

18.

Hoare, Matthew, William Gelson, Nagui M. Antoun, & Graeme J.M. Alexander. (2006). Early recurrence of neurocysticercosis after orthotopic liver transplant. Liver Transplantation. 12(3). 490–491. 14 indexed citations

19.

Unitt, Esther, Aileen Marshall, William Gelson, et al.. (2006). Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. Journal of Hepatology. 45(2). 246–253. 202 indexed citations

20.

Hoare, Matthew, William Gelson, Susan E. Davies, Martin D. Curran, & Graeme J.M. Alexander. (2005). Hepatic and intestinal schistosomiasis after orthotopic liver transplant. Liver Transplantation. 11(12). 1603–1607. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact